Similar articles

• [Long-term history of chronic hepatitis B virus infection in children].

  Fujisawa T, Inui A, Sogo T, Komatsu H. Fujisawa T, et al. Nihon Rinsho. 2004 Aug;62 Suppl 8:303-8. Nihon Rinsho. 2004. PMID: 15453335 Review. Japanese. No abstract available.
• [Treatment and selection criteria for chronic hepatitis B].

  Gunji T, Omata M. Gunji T, et al. Nihon Rinsho. 2004 Aug;62 Suppl 8:309-12. Nihon Rinsho. 2004. PMID: 15453336 Review. Japanese. No abstract available.
• [Effects of lamivudine and interferon-alpha combination therapy on chronic hepatitis B].

  Tang Y, Chen G, Zheng R. Tang Y, et al. Zhonghua Gan Zang Bing Za Zhi. 2002 Apr;10(2):89. Zhonghua Gan Zang Bing Za Zhi. 2002. PMID: 11983118 Chinese. No abstract available.
• [Combination therapy of lamivudine and HB vaccine for the treatment of chronic hepatitis B].

  Ishikawa T, Kakumu S. Ishikawa T, et al. Nihon Rinsho. 2004 Aug;62 Suppl 8:331-5. Nihon Rinsho. 2004. PMID: 15453340 Review. Japanese. No abstract available.
• Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.

  Sarin SK, Kumar M, Kumar R, Kazim SN, Guptan RC, Sakhuja P, Sharma BC. Sarin SK, et al. Am J Gastroenterol. 2005 Nov;100(11):2463-71. doi: 10.1111/j.1572-0241.2005.00247.x. Am J Gastroenterol. 2005. PMID: 16279901 Clinical Trial.